About MTaI
MTaI is an association of research-based medical technology companies who have made remarkable investments by setting up large number of R&D centres and manufacturing plants in India. MTaI represents a wide spectrum of the medical device and equipment industry with global experience in innovation and manufacturing.
All the time stressing on the three hallmarks of healthcare – Quality, Consistency and Patient Safety, we want to be a responsible voice of the industry. We are committed to improving access to affordable and quality healthcare for patients… Read More
MTaI-PwC Whitepaper
Whitepaper on the impact of COVID-19 on the MedTech & Healthcare Industry in India
Click here for details.
Thousands of contact lens businesses face disruption due to unpreparedness in sale licensing requirements: MTaI
Industry appreciates CDSCO notice to address issues but appeals to authorities to ensure proper mechanism and transition time to comply Medical Technology Association of India (MTaI) welcomed CDSCO notice GSR 754 (E)simplifying sale license requirements for retailers...
Rupee likely to remain under pressure in near term, says experts
For the second straight trading session, the rupee touched new all-time low level and closed 15 paise lower at 82.32 (provisional) against the US dollar on Friday. Surging crude oil prices, continuing apprehensions of more US Fed rate hikes and widening trade deficit...
MTaI urges the government not to levy TDS on free medical samples to doctors and clinicians
The new provisions will introduce unintended disruptions to the medtech industry and will also have ramifications throughout the entire healthcare industry Medical Technology Association of India (MTaI) has urged the government to reconsider its recently introduced...
MTaI wants states be restrained from taking price decisions on medical devices, other products
New Delhi, Jun 12 (PTI) The Medical Technology Association of India (MTaI) on Saturday said states must be restrained from intervening in price control of medical devices and other products, and the national drug price regulator should take decisions in this regard....
Govt caps trade margin on oxygen concentrators at 70%
NPPA welcomes the move, to inform revised MRPs within a week The government has decided to step-in to regulate the price of oxygen concentrators due to the recent volatility in maximum retail prices (MRP). As per information collected by the government, margin at the...
If priority products are zero rated, it would be a true removal of GST from the entire value chain: Sanjay Bhutani
GST exemptions does not necessarily lead to desired reduction in consumer prices as input GST continues to remain part of the input cost. Shahid Akhter, editor, ETHealthworld, spoke to Sanjay Bhutani, Director, Country Manager, Bausch & Lomb India & SAARC to...
